AQR Arbitrage LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$2,082,727
+1.8%
206,4150.0%0.05%
+17.8%
Q3 2022$2,046,000
+108.6%
206,415
+106.4%
0.04%
+104.5%
Q2 2022$981,000
+31.7%
100,000
+30.0%
0.02%
+4.8%
Q3 2021$745,000
+2.8%
76,900
+2.5%
0.02%
+5.0%
Q2 2021$725,000–75,000–0.02%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders